If ATR undergoes mutations or exhibits abnormal functionality, it will result in the disruption of the regulatory mechanisms governing cell proliferation, thereby posing a latent risk for the development of lung adenocarcinoma. This evidence concerns the gene ATR and lung adenocarcinoma.